Article
Absence of cognitive impairment or decline in preclinical Alzheimer's disease.
Neurology - 13 Feb 2001
Goldman W P, Price J L, Storandt M, Grant E A, McKeel D W, Rubin E H, Morris J C
Abstract excerpt
OBJECTIVE: To determine whether clinically nondemented elderly individuals with pathologically confirmed preclinical AD are characterized by cognitive decline as measured by psychometric tests before death. METHODS: Psychometric performance was examined retrospectively in 14 individuals who were nondemented at time of death and grouped in accordance with their neuropathologic findings: 1) Healthy brain (n = 9)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
